Last update: 26.10.2020 20:37 (GMT+2)

InMedica 2Y 5.5% bond (15.09.2020)

Vilnius market | First North Corporate bonds

INMB055021FA  |  ISIN LT0000404246

Trade

InMedica

InMedica

Name: UAB "InMedica" 
Core business: private healthcare services
Date of registration: 18 March 2004 
Auditor: UAB „Persense Audit“
Date of bond listing (First North): 9 March 2020 
Market: Nasdaq Vilnius

Management Board
Nerijus Drobavičius (Chairman), Rokas Grajauskas, Laura Penikienė, Ashwin Roy

Background Information
InMedica is a network of healthcare clinics which provide diagnostic and ambulatory care, surgery, dentistry and other medical services. Its healthcare professionals fully focus on each patient and their health at the group’s current 16 family medical centers, 3 broad profile clinics and 1 specialised cardio clinic in Lithuania. InMedica’s largest shareholder is the INVL Baltic Sea Growth Fund, whose main investor is the European Investment Fund – a part of the European Investment Bank. INVL Baltic Sea Growth Fund, the largest private equity investment fund for the Baltic region, is of a total €165mn size. In January 2019, the INVL Baltic Sea Growth Fund acquired a stake in InMedica” from the Baltcap private equity fund, which invested in the company in 2012.

Contact Details 
Address: L.Asanavičiūtės g. 20-201, Vilnius                     
Telephone/Fax: +370 5 265 1852 
E–mail: info@inmedica.lt
Contact person: Laura Penikienė (CEO), +370 5 265 1852

Documents

Documents

2020
March

Offer Document lt, 2 MB

Tradable Assets

Shares
Bonds
Funds

Market information

Statistics
Trading
Indexes
Auctions

Market Regulation

Rules and Regulations
Surveillance

Get Started

For Companies
For Investors
For Brokers/Members
For First North Advisers

News

Nasdaq News
Issuer News
Calendar

About Us

Nasdaq Baltic Market
Offices